| ANTX Market Cap History Table | ||||||||||||||||||||||||||||||||
Below is a table of the ANTX market cap history going back to 11/2/2022:
Also see: ANTX Shares Outstanding History and ANTX YTD Return |
As of 5/7/2026 AN2 Therapeutics has a market cap of 165.67 million. Investors often follow the ANTX market cap history to compare the size of the company over time.
This page shows ANTX market capitalization trends over time, with 15 market cap datapoints presented, dating back to 11/2/2022.

| ANTX Market Cap History Table | ||||||||||||||||||||||||||||||||
Below is a table of the ANTX market cap history going back to 11/2/2022:
Also see: ANTX Shares Outstanding History and ANTX YTD Return |
| ANTX Market Cap History Chart | |||||||||||||||||||||||||||||||||
ANTX Historical Market Cap: -14.79% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||
| ANTX Stock Price Chart |
| About AN2 Therapeutics Inc |
| AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. Co. is engaged in developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. Its initial candidate is epetraborole, which is a potential once-daily, oral treatment with a novel mechanism of action for patients with non-tuberculous mycobacterial (NTM) lung disease, a rare, chronic, and progressive infectious disease caused by bacteria known as mycobacteria, which leads to irreversible lung damage and can be fatal. Epetraborole is designed to produce broad-spectrum antimycobacterial activity through inhibition of an essential and universal step in bacterial protein synthesis. We show 15 historical shares outstanding datapoints in our ANTX shares outstanding history coverage, used to compute ANTX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ANTX market cap history over the course of time is important for investors interested in comparing ANTX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ANTX versus a peer is one thing; comparing ANTX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ANTX can fluctuate over the course of history. With this page we aim to empower investors researching ANTX by allowing them to research the ANTX market cap history. |
| ANTX Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| ANTX Share Performance |
| Market Cap Peers |
| AN2 Therapeutics (ANTX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
ANVS Market Cap History AORT Market Cap History APDN Market Cap History APEN Market Cap History APGE Market Cap History APLS Market Cap History APLT Market Cap History APM Market Cap History APR Market Cap History APRE Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.